Resolution: standard / high
Figure 5.
Cost-effectiveness of vaccines given different levels of mass vaccination coverage
by transmission setting*. Results obtained assuming a vaccine half-life of 10 years and homogeneity value
of 10, and vaccine price of US$2. *data for EIR in some cases are not shown in the
figure due to a scale problem.
Tediosi et al. Malaria Journal 2009 8:127 doi:10.1186/1475-2875-8-127
Download authors' original image